CA2232135A1 - Melanges solides de cyclodextrines prepares par fusion-extrusion - Google Patents

Melanges solides de cyclodextrines prepares par fusion-extrusion Download PDF

Info

Publication number
CA2232135A1
CA2232135A1 CA002232135A CA2232135A CA2232135A1 CA 2232135 A1 CA2232135 A1 CA 2232135A1 CA 002232135 A CA002232135 A CA 002232135A CA 2232135 A CA2232135 A CA 2232135A CA 2232135 A1 CA2232135 A1 CA 2232135A1
Authority
CA
Canada
Prior art keywords
cyclodextrin
mixture
solid mixture
active ingredient
melt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002232135A
Other languages
English (en)
Inventor
Lieven Elvire Colette Baert
Jozef Peeters
Geert Verreck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/EP1996/005118 external-priority patent/WO1997018839A1/fr
Publication of CA2232135A1 publication Critical patent/CA2232135A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

L'invention concerne un procédé pour préparer un mélange solide contenant une ou plusieurs cyclodextrines et un composant actif insoluble. Ce procédé comprend une étape de fusion-extrusion, où le composant actif est incorporé dans le vecteur cyclodextrine.
CA002232135A 1995-11-23 1996-11-20 Melanges solides de cyclodextrines prepares par fusion-extrusion Abandoned CA2232135A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95203219.1 1995-11-23
EP95203219 1995-11-23
PCT/EP1996/005118 WO1997018839A1 (fr) 1995-11-23 1996-11-20 Melanges solides de cyclodextrines prepares par fusion-extrusion

Publications (1)

Publication Number Publication Date
CA2232135A1 true CA2232135A1 (fr) 1997-05-29

Family

ID=8220858

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002232135A Abandoned CA2232135A1 (fr) 1995-11-23 1996-11-20 Melanges solides de cyclodextrines prepares par fusion-extrusion

Country Status (4)

Country Link
KR (1) KR100441109B1 (fr)
CA (1) CA2232135A1 (fr)
EA (1) EA001456B1 (fr)
TW (1) TW377357B (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5009900A (en) * 1989-10-02 1991-04-23 Nabisco Brands, Inc. Glassy matrices containing volatile and/or labile components, and processes for preparation and use thereof
KR100291361B1 (ko) * 1992-10-14 2001-09-17 니뽄 신야쿠 가부시키가이샤 결정상태의전이방법
AU5376994A (en) * 1992-11-10 1994-06-08 Nippon Shinyaku Co. Ltd. Enclosure compound manufacturing method
FR2705677B1 (fr) * 1993-05-28 1995-08-11 Roquette Freres Micro-granules obtenus par extrusion-sphéronisation contenant une cyclodextrine.

Also Published As

Publication number Publication date
EA199800347A1 (ru) 1998-10-29
TW377357B (en) 1999-12-21
KR100441109B1 (ko) 2004-10-06
EA001456B1 (ru) 2001-04-23
KR19990067009A (ko) 1999-08-16

Similar Documents

Publication Publication Date Title
AU725204B2 (en) Solid mixtures of cyclodextrins prepared via melt-extrusion
DE69222182T2 (de) Verfahren für die herstellung einer festen dispersion
EP1280559B1 (fr) Cyclodextrine acylee: complexes d'inclusion de molecule incluse
US9364546B2 (en) Melt-extruded composition comprising a cellulose ether
JP5022086B2 (ja) 医薬の剤形の使用方法
EP2822539B1 (fr) Compositions de dispersions de solides nanocristallins
MX2007014067A (es) Composiciones farmaceuticas que comprende imatinib y un retardador de liberacion.
Rajadhyax et al. Hot melt extrusion in engineering of drug cocrystals: a review
KR102388870B1 (ko) 가소제로서의 아미노 당의 용도
HUT73657A (en) Compositions in the form of solid solutions, containing coumarin derivatives
CA2232135A1 (fr) Melanges solides de cyclodextrines prepares par fusion-extrusion
CN1934109B (zh) 用于固体制剂的索非那新或其盐的组合物
Samanthula et al. Novel applications of hot melt extrusion technology
US20230338300A1 (en) Pharmaceutical composition containing cocrystals for additive manufacturing
Li et al. Hot-Melt Extrusion: An Emerging Manufacturing Technology for Drug Products
EP2852576A1 (fr) Procédé de cristallisation
Ong Development of Non-Amorphous Solid Dispersions for Poorly-Soluble Drugs Using a Novel Excipient and Hot Melt Extrusion

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead